These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Characteristics of warfarin hydroxylation catalyzed by human liver microsomes. Rettie AE, Eddy AC, Heimark LD, Gibaldi M, Trager WF. Drug Metab Dispos; 1989 Nov 15; 17(3):265-70. PubMed ID: 2568906 [Abstract] [Full Text] [Related]
18. Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe. Zhang Z, Fasco MJ, Huang Z, Guengerich FP, Kaminsky LS. Drug Metab Dispos; 1995 Dec 15; 23(12):1339-46. PubMed ID: 8689941 [Abstract] [Full Text] [Related]
19. Lansoprazole enantiomer activates human liver microsomal CYP2C9 catalytic activity in a stereospecific and substrate-specific manner. Liu KH, Kim MJ, Jung WM, Kang W, Cha IJ, Shin JG. Drug Metab Dispos; 2005 Feb 15; 33(2):209-13. PubMed ID: 15537834 [Abstract] [Full Text] [Related]
20. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites. He M, Kunze KL, Trager WF. Drug Metab Dispos; 1995 Jun 15; 23(6):659-63. PubMed ID: 7587949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]